CDNF Safe in Advanced Parkinson’s, Trial Results Show
Treatment with cerebral dopamine neurotrophic factor (CDNF), developed by Herantis Pharma, was safe and well-tolerated among patients with…
Articles by Patricia Inácio, PhD
Annovis Given US Patent for Potential Parkinson’s Treatment Expected to Enter Phase 2 Trial
Annovis Bio’s lead investigative therapy ANVS401 (also known as Posiphen) targeting protein buildup in the brain has…
Motion Machine’s Ability to Ease Motor Symptoms in Parkinson’s Entering Trial in Australia
A trial in Australia will test a motion machine, called the Reviver, to understand whether it can improve balance,…
Collaboration Formed to Develop New Radiochemicals for Diagnosing, Treating Brain Diseases
A collaborative effort between Fuzionaire Diagnostics, McGill University and The Neuro (Montreal Neurological Institute-Hospital) will foster the…
FDA Clears Way for Phase 2 Trial of AV-101 for Levodopa-Induced Dyskinesia
VistaGen Therapeutics will begin a Phase 2 clinical trial to evaluate its lead candidate AV-101 as a potential treatment…
High Blood Levels of Urate May Help Protect Dopamine-Producing Neurons in Men With Parkinson’s, Study Suggests
High levels of urate in the blood may help preserve dopamine-producing neurons and be used as a biomarker of positive…
Seelos Set to Begin Animal Studies for SLS-007 Using Gene Therapy Approach
Seelos Therapeutics will begin animal studies to test a gene therapy approach to deliver its investigational candidate SLS-007 for…
FDA Extends Abbott’s Infinity DBS System Approval to Target Additional Brain Region
The U.S. Food and Drug Administration (FDA) has expanded Abbott’s Infinity Deep Brain Stimulation (DBS) system approval to…
Case Report Describes Secondary Parkinsonism Due to Cavernoma in the Striatum
Secondary parkinsonism can be caused by a cavernoma — a cluster of abnormal blood vessels — located in a brain…
Biogen Acquires Pfizer’s PF-05251749, a Potential Disease-modifying Therapy for Parkinson’s, Alzheimer’s
Biogen is adding Pfizer’s PF-05251749 — a regulator of the body’s inner clock — to its group of potential…